Novel time-saving OGTT sparing HbA1c-HOMA2 based algorithm for the diagnosis of cystic fibrosis-related diabetes
-
Published:2024-02
Issue:
Volume:208
Page:111124
-
ISSN:0168-8227
-
Container-title:Diabetes Research and Clinical Practice
-
language:en
-
Short-container-title:Diabetes Research and Clinical Practice
Author:
Lurquin FabianORCID,
Gohy Sophie,
Hermans Michel P.,
Preumont Vanessa
Reference34 articles.
1. Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis;Weiss;Diabetes Metab,2023
2. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality;Moran;Diabetes Care,2009
3. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review;Moran;Diabetes Care,2010
4. Olesen H V, Drevinek P, Gulmans VA, et al. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al. J Cyst Fibros. 2020;19(2):321-327. doi:10.1016/j.jcf.2019.10.009.
5. ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents;Ode;Pediatr Diabetes,2022